Examkin

Soru

Zorluk: ZorGastroenterology and Hepatology

A 56-year-old man with a history of alcohol-associated cirrhosis presents to the hepatology clinic with new-onset, moderate abdominal distension and early satiety. He reports no fever, abdominal pain, or confusion. Physical examination reveals shifting dullness, spider angiomas, and palmar erythema. Ultrasound confirms the presence of moderate ascites without portal vein thrombosis or hepatocellular carcinoma.

Arrange the following interventions in the most appropriate chronological sequence for the longitudinal management of this patient's ascites, starting from the immediate next step in the current presentation to the management of highly refractory disease:

  1. 1Perform a diagnostic paracentesis with fluid analysis to rule out spontaneous bacterial peritonitis.
  2. 2Initiate dietary sodium restriction alongside baseline doses of oral spironolactone and furosemide.
  3. 3Titrate diuretic therapy to maximum tolerated doses while monitoring renal function and electrolytes.
  4. 4Conduct serial large-volume therapeutic paracenteses with intravenous albumin replacement.
  5. 5Evaluate for and place a transjugular intrahepatic portosystemic shunt (TIPS).

Cevap

The correct longitudinal sequence begins with a diagnostic paracentesis, followed by sodium restriction and baseline diuretics, titration of those diuretics to maximum doses, transitioning to serial large-volume paracenteses for refractory ascites, and finally considering TIPS placement.
The management of cirrhotic ascites follows a strict, step-wise algorithm dictated by disease severity and responsiveness to medical therapy. The absolute first step for any patient presenting with new-onset ascites is a diagnostic paracentesis to confirm the portal hypertensive etiology (SAAG ≥ 1.1 g/dL) and to rule out spontaneous bacterial peritonitis (SBP) via a polymorphonuclear cell count. Following the exclusion of infection, first-line management consists of dietary sodium restriction (< 2,000 mg/day) combined with baseline diuretic therapy, classically utilizing a 100:40 mg ratio of spironolactone to furosemide. If the ascites is not adequately mobilized, the next chronological step is the careful upward titration of these diuretics to their maximum tolerated doses (up to 400 mg spironolactone and 160 mg furosemide), with vigilant monitoring for acute kidney injury or severe hyponatremia. Ascites that persists despite maximal diuretic therapy, or cannot be treated medically due to renal or electrolyte complications, is classified as refractory. At this stage, the patient must be transitioned to serial large-volume therapeutic paracenteses, accompanied by intravenous albumin replacement (typically 6-8 g of albumin per liter of ascites removed beyond 5 liters) to prevent post-paracentesis circulatory dysfunction. Finally, if large-volume paracenteses are required too frequently (e.g., more than 2-3 times per month) or become intolerable, the placement of a transjugular intrahepatic portosystemic shunt (TIPS) is evaluated to definitively decompress the portal system.

Adım Adım Çözüm

1
Determine the immediate next step for new-onset ascites.
Diagnostic paracentesis is required.
To establish the diagnosis (SAAG >= 1.1 g/dL) and exclude subclinical spontaneous bacterial peritonitis, which dictates further management.
2
Identify the first-line therapeutic intervention for uncomplicated ascites.
Dietary sodium restriction and baseline dual diuretic therapy.
The combination of sodium restriction (< 2,000 mg/day) and spironolactone with furosemide (100:40 mg ratio) effectively mobilizes fluid while preventing potassium imbalances.
3
Determine the step for persistent but non-refractory ascites.
Titration of diuretic therapy to maximum tolerated doses.
Before labeling ascites as refractory, diuretics must be optimized to their maximum safe limits (up to 400 mg spironolactone and 160 mg furosemide) with close monitoring of creatinine and electrolytes.
4
Identify the treatment for true refractory ascites.
Serial large-volume therapeutic paracenteses.
Once diuretics fail or cause unacceptable toxicity (e.g., severe hyponatremia, AKI), the patient has refractory ascites and requires mechanical fluid removal with concurrent IV albumin to prevent post-paracentesis circulatory dysfunction.
5
Identify the definitive portal decompression strategy for highly refractory disease.
TIPS placement.
When large-volume paracenteses are needed too frequently (> 2-3 times per month), TIPS is considered to reduce portal hypertension and decrease ascites formation.

Anahtar Kavram

The progressive, step-wise management of cirrhotic ascites from diagnostic evaluation to the treatment of refractory disease.
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru